Retatrutide, an experimental drug by Eli Lilly, shows promising results in weight loss by targeting three hormones, ...

More than 90 per cent of weight loss jab users are forced to pay for treatment privately due to their slow roll-out on the ...

While it can also aid in weight loss, its branding focuses on diabetes management. According to Dr Samrat Shah, an internal ...

Ozempic, inflation and the Trump presidency will likely dictate food waste trends in the US in 2025, according to non-profit ...

Nicole Albanese, PharmD, discusses the science behind weight-loss drugs, their potential to treat other addictions as well as ...

While talk show queen Oprah Winfrey has declined to name the brand she uses, she’s among the Hollywood stars who have been ...

Eli Lilly's experimental weight loss drug, retatrutide, has demonstrated encouraging results in helping obese adults lose weight.

Some people may turn to private healthcare providers in order to get their hands on the weight loss jabs. However, Britons ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Now that Novo Nordisk is the world’s weight-loss juggernaut, will it have to betray its first patients—type 1 diabetics?

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions ...

A new request by Ozempic manufacturer Novo Nordisk could limit the availability of a type of GLP-1—semaglutides—to local ...